Status:
UNKNOWN
RetinaVue Diabetic Screening
Lead Sponsor:
Bassett Healthcare
Conditions:
Diabetic Retinopathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
the purpose of this study is to examine whether the deployment of a non-mydriatic color fundus camera in a rural prime care setting is feasible and improves the detection rate of diabetic retinopathy ...
Detailed Description
The Centers for Disease Control and Prevention (CDC) have estimated that 25.6 million Americans aged 20 years or older have either been diagnosed or undiagnosed with diabetes mellitus. As such, it is ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Type II diabetes without documented diabetic retinopathy
Exclusion
- Documented ocular pathology that may interfere with image acquisition (i.e. high grade cataract)
- Macular pathology (i.e. macular degeneration, cystoid macular edema, central serous retinopathy)
- Inability to attain analyzable RetinaVue image due to ocular pathology or other conditions (such as tremors limiting ability to maintain stable head for image)
- Acute or emergent ocular pathology that requires urgent assessment by an eye care professional as identified by the RetinaVue camera interpretation report
- Seen within the last 11 months for a diabetic eye exam.
Key Trial Info
Start Date :
February 27 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03343730
Start Date
February 27 2018
End Date
October 1 2018
Last Update
July 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bassett Medical Center
Cooperstown, New York, United States, 13326